Abstracts

Search by keyword or author name.

Showing 852 abstracts.

G Aldrovandi, P Samson, T Fenton, S Schnittman, R Rutstein, A Ortiz and the IMPAACT 1020a Study Team. Resistance to Atazanavir (ATV), Lopinavir (LPV), Tenofovir (TFV) Among Heavily Experienced Pediatric Patients. Presented at: 12th International Symposuim on HIV and Emerging Infectious Diseases; 2004 Jun 14.

Conference

12th International Symposuim on HIV and Emerging Infectious Diseases

Study

P1020A
D Baliashvili, N Gandhi, S Kim, G Churchyard, S Swindells, A Hesseling, M Hughes, S Shah for the ACTG 5300/IMPAACT 2003 PHOENIx Feasibility study team. Resistance to Mycobacterium tuberculosis infection among household contacts of MDR TB patients. Presented at: 50th Union World Conference on Lung Health.

Conference

50th Union World Conference on Lung Health

Study

IMPAACT 2003/ACTG 5300
Ross E. McKinney, Jr., M.D. Response of Antiretroviral Therapy Naive Children 3 Years Old to Monotherapy ddI or Combination ZDV/3TC: A Post Hoc Analysis of Data from PACTG Protocol 300. Presented at: 5th Conference on Retroviruses & Opportunistic Infections.

Conference

5th Conference on Retroviruses & Opportunistic Infections
Stephen A. Spector, M.D. Results of a Clinical Trial Comparing Two Doses of 2'3'-Dideoxyctidine (ddC) in the Treatment of Children with Symptomatic Human Immunodeficiency Virus (HIV) Infection who Were Intolerant or Had Failed Zidovudine (ZDV) Therapy (ACTG 138).
Stephen A. Spector, M.D. Results of a Double-Blind Placebo-Controlled Trial to Evaluate Intravenous Gamma Globulin (IVIG) in Children with Sypmtomatic HIV Infection Receiving Zidovudine (ZDV) (ACTG 051).
Stephen A. Spector, M.D. Results of a Double-Blind Placebo-Controlled Trial to Evaluate Intravenous Gamma Globulin in Children with Symptomatic HIV Infection Receiving Zidovudine (ACTG 051).
Heather Jaspan, M.D., F.A.A.P., Ph.D., D. Mark, N. Soka, L. Myer, Keren Middelkoop, A. J. Flisher, W. Christopher Mathews, M.D., M.S.P.H., Linda-Gail Bekker, MB ChB, D.C.H., Ph.D. Retention, sexual risk, and behaviour change in a cohort of HIV-negative South African adolescents. Presented at: AIDS Vaccine 2008 International Conference.

Conference

AIDS Vaccine 2008 International Conference
Jyoti Mathad, Radojka M. Savic, Paula Britto, Lubbe Wiesner, Ellen Townley, Nahida Chakhtoura, Sarah Bradford, Sandesh Patil, Tichaona Vhembo, Dominique Lespinasse, Deborah Langat, Peerawong Werarak, Portia Kamthunzi, Amita Gupta, Kelly E. Dooley. Rifapentine Pharmacokinetics and Safety in Pregnant Women with and without HIV on 3HP. Presented at: CROI 2020; 2020 Mar 11.

Conference

CROI 2020

Study

IMPAACT 2001
Mark Mirochnick, Brookie Best, Angela Kashuba, Craig Sykes, Amanda Schauer, JiaJia Wang, Alice Stek, Elizabeth Smith, Nahida Chakhtoura, Edmund Capparelli. Rilpivirine Female Genital Tract Concentrations in Pregnant and Postpartum Women. Presented at: CROI 2016; 2016 Feb 24.

Conference

CROI 2016

Study

P1026S
Lynne M. Mofenson, M.D., F.A.A.P., John S. Lambert, M.D., E. Richard Stiehm, M.D., Jean Whitehouse, Heather D. Watts, M.D., James Bethel, Ph.D., Mary Glenn Fowler, M.D., M.P.H., George J. Nemo, Ph.D. Risk Factors for Adverse Pregnancy Outcomes (APO) in HIV-Infected Pregnant women in PACTG 185.